Open AccessDifferences in rates of pelvic lymph node dissection in National Comprehensive Cancer Network favorable, unfavorable intermediate- and high-risk prostate cancer across United States SEER registries
Author(s) -
Rocco Simone Flammia,
Benedikt Hoeh,
Francesco Chierigo,
Lukas Hohenhorst,
Gabriele Sorce,
Zhen Tian,
Costantino Leonardo,
Markus Graefen,
Carlo Terrone,
Fred Saad,
Shahrokh F. Shariat,
Alberto Briganti,
Francesco Montorsi,
Felix K.H. Chun,
Michele Gallucci,
Pierre I. Karakiewicz
Publication year - 2022
Publication title -
current urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.476
H-Index - 13
eISSN - 1661-7657
pISSN - 1661-7649
DOI - 10.1097/cu9.0000000000000132
Subject(s) - medicine , prostate cancer , prostatectomy , lymph node , cancer , dissection (medical) , guideline , cancer registry , cohort , gynecology , urology , oncology , surgery , pathology
The National Comprehensive Cancer Network (NCCN) guidelines recommend pelvic lymph node dissection (PLND) in NCCN high- and intermediate-risk prostate cancer patients. We tested for PLND nonadherence (no-PLND) rates within the Surveillance Epidemiology and End Results (2010-2015).